Abstract
Gene targeting experiments have revealed that transcription factors such as c-Myb and GATA-1 play crucial roles during hematopoietic differentiation. c-Myb is necessary in the immature cells of almost every hematopoietic lineage and GATA-1 is essential for the development of the erythroid lineage. In addition, CREB-binding protein (CBP) acts as a transcriptional adapter for various transcription factors, including c-Myb and GATA-1. In this paper, we show that the transcription factors c-Myb and GATA-1 each inhibit the transcriptional activity of the other and that any possible bipartite complexes c-Myb, GATA-1, and CBP could be formed, but the tripartite complex was hardly formed. The exclusive binding of GATA-1 and c-Myb to CBP is probably the molecular basis for the mutual inhibition of their transcriptional activity. Our data suggest that cross-talk between these three factors might be important for hematopoietic differentiation and that CBP functions as a key molecule during the process.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blobel GA, Nakajima T, Eckner R, Montminy M and Orkin SH . 1998 Proc Natl Acad Sci USA 95: 2061–2066.
Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M and Evans RM . 1996 Nature 383: 99–103.
Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR and Goodman RH . 1993 Nature 365: 855–859.
Cross MA, Heyworth CM and Dexter TM . 1997 Ciba Found Symp 204: 3–14.
Dai P, Akimaru H, Tanaka Y, Hou DX, Yasukawa T, Kanei Ishii C, Takahashi T and Ishii S . 1996 Genes Dev 10: 528–540.
Ferrao P, Macmillan EM, Ashman LK and Gonda TJ . 1995 Oncogene 11: 1631–1638.
Fujiwara Y, Browne CP, Cunniff K, Goff SC and Orkin SH . 1996 Proc Natl Acad Sci USA 93: 12355–12358.
Gonda TJ, Buckmaster C and Ramsay RG . 1989a EMBO J 8: 1777–1783.
Gonda TJ, Ramsay RG and Johnson GR . 1989b EMBO J 8: 1767–1775.
Grasser FA, Graf T and Lipsick JS . 1991 Mol Cell Biol 11: 3987–3996.
Higuchi R . 1990 In Erlich, H A ed `PCR technology' Principles and Application Stockton Press New York, NY
Hu M, Krause D, Greaves M, Sharkis S, Dexter M, Heyworth C and Enver T . 1997 Genes Dev 11: 774–785.
Igarashi K, Kataoka K, Itoh K, Hayashi N, Nishizawa M and Yamamoto M . 1994 Nature 367: 568–572.
Introna M, Golay J, Frampton J, Nakano T, Ness SA and Graf T . 1990 Cell 63: 1289–1297.
Johnson AD . 1995 Cell 81: 655–658.
Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK and Rosenfeld MG . 1996 Cell 85: 403–414.
Kanei Ishii C, Tanikawa J, Nakai A, Morimoto RI and Ishii S . 1997 Science 277: 246–248.
Kwok RP, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, Roberts SG, Green MR and Goodman RH . 1994 Nature 370: 223–226.
Laemmli UK . 1970 Nature 227: 680–685.
Leff T, Elkaim R, Goding CR, Jalinot P, Sassone Corsi P, Perricaudet M, Kedinger C and Chambon P . 1984 Proc Natl Acad Sci USA 81: 4381–4385.
Lipsick JS . 1996 Oncogene 13: 223–235.
Lundblad JR, Kwok RP, Laurance ME, Harter ML and Goodman RH . 1995 Nature 374: 85–88.
Mink S, Haenig B and Klempnauer KH . 1997 Mol Cell Biol 17: 6609–6617.
Mizushima S and Nagata S . 1990 Nucleic Acids Res 18: 5322
Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott Jr W and Potter SS . 1991 Cell 65: 677–689.
Nakagoshi H, Nagase T, Kanei Ishii C, Ueno Y and Ishii S . 1990 J Biol Chem 265: 3479–3483.
Ness SA . 1996 Biochim Biophys Acta 9: 1123–1139.
Ness SA, Marknell A and Graf T . 1989 Cell 59: 1115–1125.
Niwa H, Yamamura K and Miyazaki J . 1991 Gene 108: 193–199.
Nomura T, Sakai N, Sarai A, Sudo T, Kanei Ishii C, Ramsay RG, Favier D, Gonda TJ and Ishii S . 1993 J Biol Chem 268: 21914–21923.
Oelgeschlager M, Janknecht R, Krieg J, Schreek S and Luscher B . 1996 EMBO J 15: 2771–2780.
Ogata K, Morikawa S, Nakamura H, Sekikawa A, Inoue T, Kanai H, Sarai A, Ishii S and Nishimura Y . 1994 Cell 79: 639–648.
Orita T, Shimozaki K, Murakami H and Nagata S . 1997 J Biol Chem 272: 23216–23223.
Orkin SH . 1992 Blood 80: 575–581.
Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V, Orkin SH and Costantini F . 1991 Nature 349: 257–260.
Sakura H, Kanei Ishii C, Nagase T, Nakagoshi H, Gonda TJ and Ishii S . 1989 Proc Natl Acad Sci USA 86: 5758–5762.
Shivdasani RA, Fujiwara Y, McDevitt MA and Orkin SH . 1997 EMBO J 16: 3965–3973.
Simon MC, Pevny L, Wiles MV, Keller G, Costantini F and Orkin SH . 1992 Nat Genet 1: 92–98.
Takahashi S, Onodera K, Motohashi H, Suwabe N, Hayashi N, Yanai N, Nabesima Y and Yamamoto M . 1997 J Biol Chem 272: 12611–12615.
Tsai SF, Strauss E and Orkin SH . 1991 Genes Dev 5: 919–931.
Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, Weiss MJ, Crossley M and Orkin SH . 1997 Cell 90: 109–119.
Weiss MJ, Keller G and Orkin SH . 1994 Genes Dev 8: 1184–1197.
Yasukawa T, Kanei Ishii C, Maekawa T, Fujimoto J, Yamamoto T and Ishii S . 1995 J Biol Chem 270: 25328–25331.
Acknowledgements
We thank Drs M Obinata, J Miyazaki, S Nagata, C Kanei-Ishii, T Yasukawa, J Tanikawa and T Nomura for gifting us various materials, and Drs T Habu, N Wakabayashi, N Kanno and K Isoda for valuable discussion. Dr Kelly McNagny kindly read this manuscript critically. This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture, Japanese Society for Promotion of Sciences (JSPS-RFTF98L01101), the Osaka Foundation for Promotion of Clinical Immunology and the Cell Science Research Foundation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takahashi, T., Suwabe, N., Dai, P. et al. Inhibitory interaction of c-Myb and GATA-1 via transcriptional co-activator CBP. Oncogene 19, 134–140 (2000). https://doi.org/10.1038/sj.onc.1203228
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203228
Keywords
This article is cited by
-
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
Oncogenesis (2021)
-
c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis
Molecular Cancer (2012)
-
MYB function in normal and cancer cells
Nature Reviews Cancer (2008)
-
CREB-binding proteins (CBP) as a transcriptional coactivator of GATA-2
Science in China Series C: Life Sciences (2008)
-
The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells
Oncogene (2006)